Ceribell (CBLL) Free Cash Flow (2023 - 2026)
Ceribell (CBLL) posted Free Cash Flow of -$19.3 million for Q1 2026, down 81.97% on a QoQ basis from -$10.6 million in Q4 2025, and down 69.17% year-over-year from -$62.6 million in Q1 2025.
Ceribell (CBLL) Free Cash Flow (2023 - 2026) Analysis & Trends
Ceribell's Free Cash Flow history runs 4 years deep, the most recent figure standing at -$19.3 million for Q1 2026.
- Quarterly Free Cash Flow fell 69.17% year-over-year to -$19.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$49.1 million (down 32.71% YoY) and the FY2025 annual result came in at -$41.2 million, down 17.42% from the prior year.
- Free Cash Flow was -$19.3 million for Q1 2026 at Ceribell, down from -$10.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$7.1 million in Q2 2024 and bottomed at -$19.3 million in Q1 2026.
- A 4-year average of -$10.3 million and a median of -$9.5 million in 2024 frame the typical range for Free Cash Flow.
- Annual changes were most pronounced in 2025 — Free Cash Flow slipped 8.91% — and 2026, when it plunged 69.17%.
- Ceribell's Free Cash Flow stood at -$7.2 million in 2023, then retreated by 26.64% to -$9.1 million in 2024, then dropped by 17.05% to -$10.6 million in 2025, then tumbled by 81.97% to -$19.3 million in 2026.
- Business Quant data shows CBLL's Free Cash Flow at -$19.3 million in Q1 2026, -$10.6 million in Q4 2025, and -$11.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | -19.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.29 Mn |
| Mar 31, 2026 | -19.29 Mn |
| Dec 31, 2025 | -10.60 Mn |
| Dec 31, 2025 | -10.60 Mn |
| Sep 30, 2025 | -11.46 Mn |
| Sep 30, 2025 | -11.46 Mn |
| Jun 30, 2025 | -7.76 Mn |
| Jun 30, 2025 | -7.76 Mn |
| Mar 31, 2025 | -11.40 Mn |
| Mar 31, 2025 | -11.40 Mn |
| Dec 31, 2024 | -9.06 Mn |
| Dec 31, 2024 | -9.06 Mn |
| Sep 30, 2024 | -9.42 Mn |
| Sep 30, 2024 | -9.42 Mn |
| Jun 30, 2024 | -7.12 Mn |
| Jun 30, 2024 | -7.12 Mn |
| Mar 31, 2024 | -9.50 Mn |
| Mar 31, 2024 | -9.50 Mn |
| Dec 31, 2023 | -7.15 Mn |
| Dec 31, 2023 | -7.15 Mn |